Aigenpulse launches AI-based discovery platform
The company is introducing technology using artificial intelligence and machine learning to accelerate drug discovery and development.
The company is introducing technology using artificial intelligence and machine learning to accelerate drug discovery and development.
The two firms will collaborate on an effort to integrate real-world data into clinical trial technology on a broad range of projects.
A leader with the health data specialists looks at how COVID-19 has impacted the clinical research industry, and what the future of the field might look like.